Kenneth Redon
Family · Bakersfield, CANPI 1528531274
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 30.0% of the total. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Aimmune Therapeutics, Inc.$515
- Lilly USA, LLC$293
- AstraZeneca$181
- Corcept Therapeutics$144
- plus $780 from 16 others
What the payments were for
- Food & beverage$4,384100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $1,315 |
| Novo Nordisk | 62 | $1,159 |
| Aimmune Therapeutics, Inc. | 58 | $515 |
| Lilly USA, LLC | 16 | $293 |
| AstraZeneca | 9 | $181 |
| Corcept Therapeutics | 7 | $144 |
| GSK | 1 | $125 |
| Medtronic | 2 | $111 |
| Viiv Healthcare Company | 3 | $86 |
| Nestle Healthcare Nutrition Inc. | 6 | $81 |
| Boehringer Ingelheim | 3 | $69 |
| Electromed, Inc. | 6 | $60 |
| Mannkind Corporation | 2 | $39 |
| Dexcom, Inc. | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Exact Sciences | 1 | $29 |
| Amgen | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Abiomed | 1 | $21 |
| Bayer | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 2 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,386 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 187 | $170,298 |
| ZenpepLipase/Protease/Amylase | 47 | $162,794 |
| FarxigaDapagliflozin Propanediol | 195 | $134,305 |
| JardianceEmpagliflozin | 135 | $100,753 |
| JanuviaSitagliptin Phosphate | 134 | $86,954 |
| TradjentaLinagliptin | 124 | $73,012 |
| Xigduo XrDapaglifloz Propaned/Metformin | 97 | $52,795 |
| LinzessLinaclotide | 85 | $52,002 |
| RybelsusSemaglutide | 33 | $38,891 |
| EliquisApixaban | 26 | $22,591 |
| TrulicityDulaglutide | 16 | $18,603 |
| Diclofenac Sodium | 108 | $14,300 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 50 | $13,267 |
| KerendiaFinerenone | 19 | $12,196 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 15 | $11,780 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,159 | $209,189220 claims |
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Combivent Respimat | $69 | $191,790287 claims |
| Aimmune Therapeutics, Inc.Zenpep | $515 | $162,79447 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $181 | $141,181207 claims |
| AbbVieLinzess | $1,315 | $52,00285 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $293 | $29,33127 claims |
| BayerKerendia | $18 | $12,19619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Bakersfield
- Jennifer TougasBakersfield$302K
- Ashton ChaseBakersfield$86K
- Durish Ann DorotheoBakersfield$25K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.